Inventor
ARUFFO ALEJANDRO A
US16 patents
⚠️ This page may combine multiple inventors who share the name “ARUFFO ALEJANDRO A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
15 patentsUS5916560AJun 29, 1999
Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith
BRISTOL MYERS SQUIBB CO175 citations98
US5709859AJan 20, 1998
Mixed specificity fusion proteins
BRISTOL MYERS SQUIBB CO143 citations98
US6051228AApr 18, 2000
Antibodies against human CD40
BRISTOL MYERS SQUIBB CO202 citations97
US6210669B1Apr 3, 2001
Methods and compositions for immunomodulation
BRISTOL MYERS SQUIBB CO194 citations96
US5663151ASep 2, 1997
Sulfated α-glycolipid derivatives as cell adhesion inhibitors
BRISTOL MYERS SQUIBB CO68 citations96
US6376459B1Apr 23, 2002
Inhibiting B cell activation with soluble CD40 or fusion proteins thereof
BRISTOL MYERS SQUIBB CO58 citations95
US5993800ANov 30, 1999
Methods for prolonging the expression of a heterologous gene of interest using soluble CTLA4 molecules and an antiCD40 ligand
BRISTOL MYERS SQUIBB CO93 citations95
US5876950AMar 2, 1999
Monoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapy
BRISTOL MYERS SQUIBB CO115 citations95
US6372215B1Apr 16, 2002
Monoclonal antibodies to human CD6
BRISTOL MYERS SQUIBB CO55 citations93
US6472510B1Oct 29, 2002
CD40 receptor ligands
BRISTOL MYERS SQUIBB CO35 citations92
US6413514B1Jul 2, 2002
Methods of using antibodies against human CD40
BRISTOL MYERS SQUIBB CO35 citations91
US5861151AJan 19, 1999
Soluble fusion molecules with binding specificity for cell adhesion molecules
BRISTOL MYERS SQUIBB CO10 citations70
US6046314AApr 4, 2000
Spα: a novel scavenger receptor cysteine-rich domain-containing polypeptide, and monoclonal antibodies thereto
BRISTOL MYERS SQUIBB CO7 citations68
US5565433AOct 15, 1996
Sulfated β-glycolipid derivatives as cell adhesion inhibitors
BRISTOL MYERS SQUIBB CO5 citations63
US6559287B1May 6, 2003
Artificial proteoglycans
BRISTOL MYERS SQUIBB CO5 citations53